Discontinuation report GEMCITABINE FOR INJECTION, USP
Report ID | 6698 |
Drug Identification Number | 02407302 |
Brand name | GEMCITABINE FOR INJECTION, USP |
Common or Proper name | Gemcitabine |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GEMCITABINE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-04-12 |
Remaining supply date | 2017-04-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-13 | English | Compare |
v2 | 2017-04-13 | French | Compare |
Showing 1 to 2 of 2